API GMP Certified Factory

Lianhe Aigen operates multiple API GMP manufacturing facilities for small molecule active pharmaceutical ingredients (APIs), providing controlled production environments, quality systems, analytical support, and manufacturing capabilities from clinical development through commercial supply.

With more than 500 m³ of reactor capacity across multiple production sites, our API GMP manufacturing platform supports small molecule APIs, high-potency APIs (HPAPIs), and specialized synthesis. Manufacturing infrastructure includes GMP production areas, controlled environments, high-containment capabilities, solvent recovery systems, automation, and batch traceability.

Lianhe Aigen's manufacturing sites have undergone inspections involving major health authorities, including the US FDA, EMA, NMPA, PMDA, and TGA. Our API GMP manufacturing system integrates production, quality control, analytical testing, documentation, and regulatory support to meet the requirements of regulated pharmaceutical markets.

API GMP Manufacturing at a Glance

500+ m³ reactor capacity | Small Molecule APIs | HPAPI Manufacturing | Clinical to Commercial Supply | Global Regulatory Experience

GMP API Manufacturing Facility

A qualified API GMP manufacturing facility requires more than production capacity. Pharmaceutical manufacturers need appropriate equipment, controlled production environments, validated processes, analytical capabilities, documented GMP procedures, and a quality management system capable of supporting regulatory review.

Lianhe Aigen's GMP API manufacturing infrastructure is designed to connect these capabilities within one manufacturing system. The facilities support:

Small molecule API manufacturing
High-potency API and specialized synthesis
GMP batch manufacturing
Process scale-up and manufacturing technology transfer
Clinical-stage API supply
Commercial API production
Analytical testing and quality control
Regulatory documentation and inspection support

This facility-focused approach differentiates the API GMP certified factory from general API development services. For process chemistry and API development capabilities, see our API Production Company service.

API Manufacturing Capacity and Facility Infrastructure

Lianhe Aigen provides API manufacturing capacity for pharmaceutical programs progressing from development and clinical supply to larger-scale GMP and commercial production. More than 500 m³ of reactor capacity is available across multiple production sites.

Capability	Lianhe Aigen Support
Reactor capacity	More than 500 m³ across multiple production sites
API manufacturing scope	Small molecule APIs, HPAPIs, and specialized synthesis
Manufacturing stages	Clinical development through commercial manufacturing
Scale-up	Laboratory, kilo, pilot, GMP, and production-scale activities
Manufacturing environment	GMP production areas, controlled environments, and applicable cleanroom facilities
Containment	High-containment capabilities for applicable potent compounds
Supporting systems	Automation, solvent recovery, material control, and batch traceability
Quality system	Centralized quality management and documented GMP procedures
Analytical support	HPLC, GC, LC-MS, ICP-MS, and microbiological testing platforms
Manufacturing support	Technology transfer, scale-up, GMP batch production, and commercial supply
Regulatory support	Experience with FDA, EMA, NMPA, PMDA, TGA, and other regulated-market requirements

Small Molecule API Manufacturing

The core of our API GMP manufacturing platform is small molecule production. Lianhe Aigen supports manufacturing processes involving conventional and complex synthetic chemistry, with production capabilities designed to accommodate different process conditions and manufacturing requirements.

Complex Synthesis

Multi-step organic synthesis
Chiral synthesis
Fluorination
Halogenation
Nitration
Enzymatic reactions

```

Specialized Processing

Hydrogenation
High-pressure chemistry
Cryogenic processing
High-temperature processing
Flow chemistry
Specialized and hazardous chemistry

```

These capabilities are supported by Lianhe Aigen's broader Production Technology Platform, which applies technologies such as flow chemistry, enzyme catalysis, electrochemistry, and photochemistry to pharmaceutical production.

High-Potency API and Specialized Manufacturing

HPAPI manufacturing requires additional controls compared with conventional API production because potent compounds may require specialized containment, material handling, cleaning, and cross-contamination controls.

Lianhe Aigen provides high-potency API manufacturing capabilities for applicable compounds, supported by controlled production environments and quality and safety procedures.

High-containment manufacturing environments
Controlled material handling and transfer
Containment controls for applicable potent compounds
Cleaning and cross-contamination control
Process and manufacturing safety assessment
Specialized analytical testing
GMP documentation and batch traceability

HPAPI manufacturing requirements are evaluated according to the compound, process, scale, and applicable containment requirements rather than applying one standard production configuration to every molecule.

API GMP Manufacturing from Scale-Up to Commercial Production

An API GMP manufacturing facility must be able to convert a developed process into a controlled and repeatable manufacturing process. Lianhe Aigen connects process development, engineering, production, analytical, quality, and regulatory functions during this transition.

Process Transfer

Manufacturing process information, analytical methods, material requirements, equipment considerations, process parameters, and control strategies are reviewed before GMP manufacturing begins.

Scale-Up

Laboratory or pilot processes are assessed for larger-scale production, including reaction conditions, mixing, heat transfer, addition rates, impurity formation, isolation, and process safety.

GMP Batch Manufacturing

The transferred process is executed under approved GMP procedures with controlled production operations, in-process controls, manufacturing documentation, and batch records.

Process Validation

Where required by the development and regulatory stage, validation activities establish that the manufacturing process can consistently produce API meeting predefined quality requirements.

Commercial API Manufacturing

Validated manufacturing processes can progress to larger-scale production for commercial supply, subject to the applicable product, regulatory, and quality requirements.

This scale-up pathway is particularly important because commercial API production is not simply laboratory synthesis at a larger volume. Equipment behavior, heat and mass transfer, impurity formation, process control, and material handling must remain controlled as production scale increases.

Technology Transfer to GMP Manufacturing

Technology transfer connects API process development with GMP manufacturing. Lianhe Aigen brings process development, production, analytical, quality, engineering, and regulatory functions together to support the transfer of a manufacturing process into an API GMP facility.

Manufacturing process documentation
Raw material and starting material specifications
Equipment and process parameter requirements
Critical process parameters and in-process controls
Analytical methods and specifications
Impurity profiles and control strategies
Cleaning requirements
Process safety considerations
Batch manufacturing records
Scale-up observations and validation requirements

For projects that require further process optimization before GMP production, our Process Development service covers process development, optimization, analytical development, scale-up, process safety, and CMC-related activities.

GMP Quality Management System

Reliable API GMP manufacturing depends on a documented quality management system covering manufacturing activities, analytical testing, deviations, changes, records, and batch release.

Quality Management

Validated standard operating procedures
Change control
Deviation investigation
CAPA management
OOS investigation
Batch record review

```

Validation and Compliance

Analytical method validation
Cleaning validation
Equipment qualification
Process validation
Data integrity
Documentation control

```

Lianhe Aigen follows GMP management practices throughout API and intermediate process development, production, storage, testing, and process submission or review. Quality systems are designed to maintain data integrity, reliability, and traceability throughout the product lifecycle.

For broader quality and regulatory information, see Quality & Compliance.

Analytical Testing and Quality Control for APIs

Analytical control is an integral part of API manufacturing. Lianhe Aigen's analytical and QC infrastructure supports raw material testing, in-process control, API release testing, impurity characterization, and other quality investigations.

Analytical Capability	Manufacturing Application
HPLC	Assay, purity, impurity profiling, and release testing
GC	Volatile components, residual solvents, and related testing
LC-MS	Structural confirmation and impurity investigation
ICP-MS	Elemental impurity testing
Microbiological platforms	Applicable microbiological quality testing

Analytical activities can include raw material testing, in-process testing, API release testing, impurity analysis, residual solvent testing, elemental impurity testing, analytical method development and validation, and stability support.

Regulatory Compliance and Inspection Support

An API GMP certified manufacturing facility serving global pharmaceutical markets must be prepared for regulatory review and customer audits. Lianhe Aigen's manufacturing sites have experience with inspections and regulatory requirements involving major global health authorities.

US FDA
EMA
NMPA
PMDA
TGA
KFDA and other applicable regulatory requirements

Regulatory and quality support can include:

GMP manufacturing documentation
CMC information
Drug Master File (DMF) support
Manufacturing process documentation
Analytical data and validation documentation
Regulatory response support
Customer audit preparation
Health authority inspection support

Lianhe Aigen's website records quality and regulatory experience involving FDA, EMA, TGA, PMDA, KFDA, and NMPA, while its manufacturing facilities have been inspected or overseen by relevant health authorities.

API GMP Manufacturing for Clinical and Commercial Programs

The manufacturing requirements of an API change as a pharmaceutical program moves from preclinical development to commercial supply. Lianhe Aigen's API GMP manufacturing capabilities can support different development stages.

Development Stage	API GMP Manufacturing Focus
Preclinical	Process confirmation, manufacturing development, and development material
Phase I	Clinical API manufacturing and controlled GMP production
Phase II	Process refinement, scale-up, and clinical supply
Phase III	Larger-scale GMP manufacturing, process validation, and supply preparation
Commercial	Validated production, batch release, and ongoing API supply
Post-approval	Continued manufacturing and lifecycle support

For outsourced manufacturing projects that require broader project management and commercial manufacturing support, see our Contract API Manufacturing service.

API GMP Manufacturing Process

A typical GMP API manufacturing process connects technology transfer, manufacturing execution, analytical testing, quality review, and final batch release.

Technology Transfer
Review the manufacturing process, analytical methods, materials, equipment requirements, and critical process information.
Scale-Up Assessment
Evaluate process behavior, equipment suitability, manufacturing risks, and scale-dependent process parameters.
Manufacturing Preparation
Confirm raw materials, equipment, production documentation, analytical requirements, and quality controls.
GMP Batch Manufacturing
Execute the manufacturing process under approved GMP procedures and controlled production conditions.
In-Process Control
Monitor applicable process parameters and intermediate quality attributes during manufacturing.
QC Testing
Perform required analytical testing using qualified methods and appropriate laboratory instrumentation.
Batch Review
Review production records, analytical results, deviations, and other required documentation.
API Release
Release the finished API according to applicable quality and regulatory requirements.

Manufacturing Technologies for Complex API Processes

Lianhe Aigen combines conventional API production infrastructure with specialized technologies for challenging pharmaceutical processes. The technology selected for a project depends on the molecule, reaction conditions, scale, safety requirements, and target manufacturing process.

Flow Chemistry

Continuous flow processing can be applied to selected reactions where improved heat transfer, reaction control, safety, or process consistency provides manufacturing advantages.

```

Hydrogenation

Specialized production capabilities support hydrogenation processes used in selected API and pharmaceutical intermediate manufacturing routes.

Cryogenic Chemistry

Controlled low-temperature processing supports selected reactions that require cryogenic operating conditions during API synthesis.

Enzymatic Chemistry

Enzyme-based reactions can provide alternative synthetic routes for selected pharmaceutical transformations where high selectivity or process efficiency is required.

```

API Manufacturing Facility Designed for Quality and Supply Continuity

An API manufacturing facility must balance production capacity with quality, safety, maintenance, and supply continuity. Lianhe Aigen's manufacturing network combines multiple production sites with centralized quality management and supporting analytical and technology platforms.

Multiple API GMP manufacturing sites
More than 500 m³ of reactor capacity
Small molecule API and specialized manufacturing capabilities
HPAPI and high-containment capabilities
Centralized quality management
Analytical and QC infrastructure
Solvent recovery systems
Production automation
Material and batch traceability
Technology transfer and scale-up support

Lianhe Aigen's production technology platform also connects kilogram-scale development, pilot production, and cGMP multifunctional manufacturing capabilities, helping bridge the gap between process development and larger-scale pharmaceutical production.

Why Choose Lianhe Aigen as an API GMP Manufacturing Partner?

500+ m³ Reactor Capacity

More than 500 m³ of reactor capacity across multiple production sites provides manufacturing capacity for different small molecule API programs and production stages.

```

Global Regulatory Experience

Manufacturing sites have experience with inspections and regulatory requirements involving FDA, EMA, NMPA, PMDA, TGA, and other regulated markets.

Integrated Manufacturing Support

Process development, scale-up, analytical, quality, engineering, regulatory, and manufacturing teams can work within one organization.

Small Molecule and HPAPI Capabilities

The manufacturing platform supports conventional small molecule APIs together with high-potency and specialized compounds requiring additional production controls.

Established Analytical Infrastructure

HPLC, GC, LC-MS, ICP-MS, and microbiological platforms support raw material, in-process, release, and quality-control activities.

Clinical to Commercial Supply

API GMP manufacturing capabilities support pharmaceutical programs as they progress from clinical supply toward commercial manufacturing.

```

API GMP Factory vs. API Development Services

Lianhe Aigen provides both API development and API manufacturing capabilities, but this page focuses specifically on the API GMP manufacturing facility, its production infrastructure, quality systems, and manufacturing controls.

Requirement	API GMP Certified Factory	API Development / Production Service
GMP batch manufacturing	Primary capability	Supporting capability
Production facility	Primary focus	Supporting capability
Reactor capacity	Primary focus	Supporting capability
GMP quality system	Primary focus	Supporting capability
Regulatory inspection support	Primary focus	Supporting capability
Process development	Supporting capability	Core focus
Route scouting	Supporting capability	Core focus
Scale-up	Core manufacturing capability	Core development capability
Technology transfer	Core manufacturing capability	Core development capability
Commercial API supply	Core manufacturing capability	Available through manufacturing platform

For broader API development, process chemistry, and production capabilities, visit our API Production Company page.

Related API Manufacturing Services

FAQ About API GMP Certified Factories

What is an API GMP certified factory?

An API GMP certified factory is a pharmaceutical manufacturing facility that operates under applicable Good Manufacturing Practice requirements for producing active pharmaceutical ingredients. Depending on the market and product, the facility may also be subject to regulatory inspections, certificates, registrations, or other applicable regulatory requirements.

Does Lianhe Aigen manufacture APIs under GMP conditions?

Yes. Lianhe Aigen operates multiple GMP manufacturing sites supporting small molecule API production, HPAPI, and specialized synthesis. Its manufacturing network has experience with global health authority inspections and regulated-market requirements.

What is the API manufacturing capacity of Lianhe Aigen?

Lianhe Aigen's API GMP manufacturing network has more than 500 m³ of reactor capacity across multiple production sites. The appropriate production scale and equipment depend on the molecule, process, manufacturing stage, and product requirements.

Can the API GMP factory support commercial manufacturing?

Yes. Lianhe Aigen's manufacturing platform supports API programs from clinical development through commercial production, combining GMP manufacturing, analytical QC, quality management, and regulatory support.

Can Lianhe Aigen manufacture HPAPIs?

Lianhe Aigen provides manufacturing capabilities for high-potency APIs and specialized synthesis, supported by high-containment environments and applicable quality and safety controls.

What analytical equipment is available for API quality control?

Lianhe Aigen's analytical and QC infrastructure includes HPLC, GC, LC-MS, ICP-MS, and microbiological testing platforms. These capabilities support raw material testing, in-process control, API release testing, impurity analysis, and other quality-control activities.

Does Lianhe Aigen support technology transfer to GMP manufacturing?

Yes. Technology transfer and scale-up connect process development with GMP manufacturing. Transfer activities can cover process documentation, analytical methods, materials, equipment requirements, process parameters, in-process controls, and validation requirements.

Which regulatory markets can Lianhe Aigen support?

Lianhe Aigen has experience with regulated markets involving authorities such as the US FDA, EMA, NMPA, PMDA, and TGA. Its quality and compliance infrastructure supports documentation and manufacturing requirements for global API supply.

Discuss Your API GMP Manufacturing Requirements

Whether you are preparing a clinical API program, transferring an established process into GMP production, or planning commercial API supply, Lianhe Aigen can provide the manufacturing infrastructure, quality systems, analytical support, and regulatory experience required for your program.

Contact Lianhe Aigen to discuss your API manufacturing requirements, production scale, technology transfer needs, HPAPI requirements, and applicable GMP standards.